Skip navigation

Chemical 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide

Name 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide
Equivalent Term K II analgesic
CAS Registry Number 106709-52-8
Structure 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide
Curation Status No associations have been curated for this chemical yet.
MeSH® ID C052660
External Links

Top ↑ Ancestors

1. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Amides Has associated genes Has associated diseases Has associated exposure references Acetamides Has associated genes Has associated diseases Has associated exposure references Benzeneacetamides Has associated genes Has associated diseases 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide
2. ChemicalsOrganic Chemicals Has associated genes Has associated diseases Has associated exposure references Hydrocarbons Has associated genes Has associated diseases Has associated exposure references Hydrocarbons, Cyclic Has associated genes Has associated diseases Has associated exposure references Hydrocarbons, Aromatic Has associated genes Has associated diseases Has associated exposure references Benzene Derivatives Has associated genes Has associated diseases Has associated exposure references Benzeneacetamides Has associated genes Has associated diseases 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide
3. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 1-Ring Has associated genes Has associated diseases Has associated exposure references Azoles Has associated genes Has associated diseases Has associated exposure references Pyrroles Has associated genes Has associated diseases Has associated exposure references 3,4-dichloro-N-methyl-N-(2-(1-delta(3)-pyrrolinyl)-cyclohexyl)benzeneacetamide

Top ↑ Descendants

None.